U.S. markets closed

JNJ Chief Scientific Officer on vaccine: Good results in preclinical trials speeding up process

Johnson & Johnson moved the start of human trials for its potential coronavirus vaccine to begin in July. Johnson & Johnson Chief Scientific Officer Dr. Paul Stoffels joins Yahoo Finance’s On The Move panel to discuss.